Drugs / LM-364
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07694765 | Jul 2026 → Dec 2028 expected | cancer | LaNova Medicines Limited | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LM-364 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07694765 ↗ |
| Route | Intravenous | “Q3W, Intravenous Drip” NCT07694765 ↗ |